15-45110685-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001363711.2(DUOX2):āc.908C>Gā(p.Pro303Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0136 in 1,612,426 control chromosomes in the GnomAD database, including 186 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.011 ( 21 hom., cov: 32)
Exomes š: 0.014 ( 165 hom. )
Consequence
DUOX2
NM_001363711.2 missense
NM_001363711.2 missense
Scores
7
4
7
Clinical Significance
Conservation
PhyloP100: 7.19
Genes affected
DUOX2 (HGNC:13273): (dual oxidase 2) The protein encoded by this gene is a glycoprotein and a member of the NADPH oxidase family. The synthesis of thyroid hormone is catalyzed by a protein complex located at the apical membrane of thyroid follicular cells. This complex contains an iodide transporter, thyroperoxidase, and a peroxide generating system that includes this encoded protein and DUOX1. This protein is known as dual oxidase because it has both a peroxidase homology domain and a gp91phox domain. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012326807).
BP6
Variant 15-45110685-G-C is Benign according to our data. Variant chr15-45110685-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 260328.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=3}. Variant chr15-45110685-G-C is described in Lovd as [Likely_benign]. Variant chr15-45110685-G-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0106 (1616/152278) while in subpopulation NFE AF= 0.0165 (1121/68026). AF 95% confidence interval is 0.0157. There are 21 homozygotes in gnomad4. There are 680 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 21 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUOX2 | NM_001363711.2 | c.908C>G | p.Pro303Arg | missense_variant | 8/34 | ENST00000389039.11 | NP_001350640.1 | |
DUOX2 | NM_014080.5 | c.908C>G | p.Pro303Arg | missense_variant | 8/34 | NP_054799.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUOX2 | ENST00000389039.11 | c.908C>G | p.Pro303Arg | missense_variant | 8/34 | 1 | NM_001363711.2 | ENSP00000373691.7 | ||
DUOX2 | ENST00000603300.1 | c.908C>G | p.Pro303Arg | missense_variant | 8/34 | 1 | ENSP00000475084.1 | |||
DUOX2 | ENST00000558383.1 | n.1239C>G | non_coding_transcript_exon_variant | 5/17 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1615AN: 152160Hom.: 21 Cov.: 32
GnomAD3 genomes
AF:
AC:
1615
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0109 AC: 2740AN: 251084Hom.: 23 AF XY: 0.0105 AC XY: 1430AN XY: 135786
GnomAD3 exomes
AF:
AC:
2740
AN:
251084
Hom.:
AF XY:
AC XY:
1430
AN XY:
135786
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0139 AC: 20333AN: 1460148Hom.: 165 Cov.: 32 AF XY: 0.0137 AC XY: 9930AN XY: 726400
GnomAD4 exome
AF:
AC:
20333
AN:
1460148
Hom.:
Cov.:
32
AF XY:
AC XY:
9930
AN XY:
726400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0106 AC: 1616AN: 152278Hom.: 21 Cov.: 32 AF XY: 0.00913 AC XY: 680AN XY: 74454
GnomAD4 genome
AF:
AC:
1616
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
680
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
11
ESP6500EA
AF:
AC:
152
ExAC
AF:
AC:
1292
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | This variant is associated with the following publications: (PMID: 31030636, 27373512) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Thyroid dyshormonogenesis 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;H
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;.
REVEL
Pathogenic
Sift
Uncertain
D;.
Sift4G
Pathogenic
D;D
Polyphen
1.0
.;D
Vest4
MPC
0.38
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at